Many providers feel ill-equipped to treat opioid use disorder with medications, like any other chronic disease. A new tool from BMC's OBAT program may help.
New research shows that pupillometry using an automated camera could improve treatment for opioid withdrawal symptoms and outcomes.
Treatment and harm reduction approaches for opioid use disorder have failed to effectively meet the needs of people of color, experts say.
Miriam Komaromy, MD, medical director for the Grayken Center for Addiction at BMC, reacts to the news of increased access to a key medication for opioid use disorder.